Mr. Bah oversees quality improvement, care management, utilization management, pharmacy and clinical programs for EmblemHealth, translating data into targeted interventions that improve access and outcomes. Under his leadership, the organization earned the 2025 Pharmacy Quality Alliance “Quality Improvement Award” after achieving a 38% improvement in key pharmacy quality metrics for its dual-eligible Medicare D-SNP plan and a 37% improvement across other Medicare lines. He spearheaded the 2024 launch of the community diabetes wellness program in the Bronx, offering free A1C screenings, prevention workshops and nutritional counseling to the public. In 2023, he guided EmblemHealth to become the first insurer in New York State to earn National Committee for Quality Assurance health equity accreditation across three product lines. Mr. Bah also created New York’s first pharmacy value-based arrangement for chronic disease management, enabling over 4,000 network pharmacies to provide A1C and blood pressure screenings and coordinate follow-up care. His initiatives have set a regional benchmark for equity in managed care and strengthened the organization’s ability to address chronic conditions while closing care gaps.
